key: cord-1016261-pfu6q0v1
authors: Rojas-Gallardo, D. M.; Garzon-Castano, S. C.; Millan, N.; Jimenez-Posada, E. V.; Cardona-Ospina, J. A.
title: COVID-19 in Latin America: Contrasting phylodynamic inference with epidemiological surveillance.
date: 2020-05-26
journal: nan
DOI: 10.1101/2020.05.23.20111443
sha: b058d343b9c5c97d37d29aaca7a311be4e04770a
doc_id: 1016261
cord_uid: pfu6q0v1

Introduction: SARS-CoV-2 infection has represented the one of the largest challenges for humanity. This virus was first detected in Latin America and the Caribbean (LAC) in Brazil in February 26, 2020 and it has revealed important gaps in infectious disease surveillance that must be covered. Phylodynamic analysis is a tool that can help to monitor and adapt traditional surveillance measures in order to cover those. Therefore, this work aims to contrast data driven from epidemiologic surveillance in LAC with parameters inferred from phylodynamic analysis of reported genomes of SARS-CoV-2 across different LAC countries Methods: We obtained epidemiological data from daily reports provided by European Centre for Disease Prevention and Control up to 13th May, 2020. We estimated Effective Reproductive Number (Re) and calculated epidemic curves with exponential growth (EG) and maximum likelihood (ML) methods. SARS-CoV-2 phylodynamic in Latin-American was analyzed using sequences reported in GISAID for Central and South America up to May 13th 2020. Sequences were aligned, and ML phylogeny was constructed. Coalescent model Birth Death SIR (serial) was run, and SIR trajectories from the birth-death SIR model were plotted. Results: A total of 404,448 cases were reported up to 13th May 2020. Overall reproduction number for Latin America, estimated through the EG and ML methods, were 1.424 (IC95% 1.422 to 1.426) and 1.305 (IC95% 1.299 to 1.311) respectively. Phylodynamic analysis for Latin America showed an overall Re of 1.27 (IC95% 1.07 to 1.49). We did not find statistically significant differences between epidemiological and phylodynamic data at the cut-off time, except for Brazil. Discussion: Our results support that epidemiological and genomic surveillance are two complementary approaches. Evidence suggests that even with a low number of sequences proper estimations of Re could be performed. We suggest that countries, especially developing countries, should consider to add genomic surveillance to their systems for monitoring and adapting epidemiological surveillance of SARS-CoV-2.

Introduction: SARS-CoV-2 infection has represented the one of the largest challenges for 23

in February 26, 2020 and it has revealed important gaps in infectious disease surveillance 25 that must be covered. Phylodynamic analysis is a tool that can help to monitor and adapt 26 traditional surveillance measures in order to cover those. Therefore, this work aims to 27 contrast data driven from epidemiologic surveillance in LAC with parameters inferred from 28 phylodynamic analysis of reported genomes of SARS-CoV-2 across different LAC 29 countries Methods: We obtained epidemiological data from daily reports provided by 30

European Centre for Disease Prevention and Control up to 13 th May, 2020. We estimated 31

Effective Reproductive Number (Re) and calculated epidemic curves with exponential 32 growth (EG) and maximum likelihood (ML) methods. SARS-CoV-2 phylodynamic in 33

Latin-American was analyzed using sequences reported in GISAID for Central and South 34

America up to May 13 th 2020. Sequences were aligned, and ML phylogeny was 35 constructed. Coalescent model Birth Death SIR (serial) was run, and SIR trajectories from 36 the birth-death SIR model were plotted. Results: A total of 404,448 cases were reported up 37 to 13 th May 2020. Overall reproduction number for Latin America, estimated through the 38 EG and ML methods, were 1.424 (IC95% 1.422 to 1.426) and 1.305 (IC95% 1.299 to 39 1.311) respectively. Phylodynamic analysis for Latin America showed an overall Re of 40 1.27 (IC95% 1.07 to 1.49). We did not find statistically significant differences between 41 epidemiological and phylodynamic data at the cut-off time, except for Brazil. were obtained, as well as fatal cases. We calculated Case Fatality Rates (CFR) = number of 89 reported deaths/number of total cases) X 100, and estimated Re and epidemiologic curves 90 using exponential growth and maximum likelihood methods [11] [12] [13] . 91 92

In order to estimate Re, we estimated the Generation time (GT) using the R package R0 11 . 95

The distribution of the generation time, considered as the time between a primary infected 96 case and a secondary case, was estimated by Maximun Likelihood using the serial time 97 between infectee/infector pairs published by He et al, 2020 11, 14 . Then, Re at the beginning 98 of the epidemic, and its evolution through time were estimated using Exponential Growth 99 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 /2020 (EG) and Maximum Likelihood (ML) methods 12, 13, 15 . The time period over which growth 100 is exponential was estimated using the deviance R-squared statistic over a range of possible 101 time periods 11 . 102 103 Dataset for phylodynamic analysis 104

In order to investigate de SARS-CoV-2 phylodynamic in Latin-American, we search for 106 sequences reported in GISAID 16 for Central and South America up to May 13 th 2020. We 107 choose only whole genome sequences (>29,900) of the virus with high coverage, and more 108 than 95% of nucleotide base resolved. We conserved identical sequences with different 109 sampling dates and different location and discard identical sequences with same sampling 110 date between countries. Accession IDs, sampling dates and locations of the sequences were 111 obtained, as well as clinical metadata when available. We also generated subgroup datasets 112 for each country reporting at least five sequences. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . We conducted a sensitivity analysis computing the R-squared statistic over a 141 range of possible time periods for exponential growth (begin between days 1 to 39, and 142 ending between days 40 to 79), selecting the best fit for EG and ML analysis. In order to 143 assess the effect of GT distribution variation on Re estimation, we computed the 144 reproduction ratio over a range of chosen generation time distributions with mean between 145 1 to 14 days, assuming fixed standard deviation, and using ML method. 146 147 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . respectively. The epidemic curve and time dependent analysis is showed in Figure 1 . The 161 portion of the epidemic curve that best fitted exponential growth was estimated between 162 2020-02-26 and 2020-04-11 (first 45 days), with a Growth Rate of 11.91%, and a Re of 163 1.95 (IC95% 1.94 to 1.95) and 1.74351(IC95% 1.72 to 1.77) through EG and ML method, 164

respectively. Sensitivity analysis showed that Re remained within the 95%IC only for a 165 small choice of time windows Figure 1c , and that varied significantly across different GT 166 distributions (data not shown). 167 168 For Latin American ML phylogenetic reconstruction, the GTR+I+G was the best model of 169 nucleotide substitution for the data set (substitution rates for every data set is showed in 170

Supplementary Table 2 ). The PHI test did not found statistically significant evidence for 171 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. Table 1 . 187

When contrasting observed and inferred Re, we did not find statistically significant 188 differences between epidemiological and phylodynamic data at the cut-off time, except for 189 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. However, SIR trajectories revealed disagreement in terms of incident cases, total cases and 216 recovered cases. For some countries, recovered cases were higher than incident cases, like 217 for example Argentina and Brazil (Figure 3) . We hypothesize that this disagreement could 218 be related with the real origin of the sequences reported from each country and the real date 219 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 /2020 of SARS-CoV-2 introduction. Since most of sequences available when the analysis was 220 performed were reported at the beginning of the epidemic in each country, it is possible that 221 genomic data did not reveal internal transmission networks but external transmission 222 networks from imported cases. This could be supported on the analysis of ML phylogenetic 223 tree, which did not reveal a space related distribution. Overall Re estimation for LAC through phylodynamic analysis showed good agreement 235 with observed Re through epidemiological surveillance even when sequences were not 236 available from every country. Evidence suggests that even with a low number of sequences, 237

proper estimations of Re could be performed. This could provide important insights, 238 especially at the beginning of an epidemic when epidemiological surveillance systems are 239 adjusting follow-up and control measures. At the same time, we found that the lack of 240 clinical and epidemiological metadata for reported sequences difficult making 241 phylodynamic inferences. We suggest that countries, especially developing countries, 242 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 /2020 should consider to add genomic surveillance to their systems for monitoring and adapting 243 epidemiological surveillance of SARS-CoV-2. 244 245

We would like to acknowledge Grupo de Investigación SIRIUS, Facultad de Ingenierias, 247

Universidad Tecnológica de Pereira, for providing resources for performing high 248 performance computational analysis. We also want to acknowledge the laboratories that 249 have contributed publicly available genomes via GISAID in Latin America. 250 251 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020 . . https://doi.org/10.1101 /2020 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 26, 2020. . May 13 th , 2020, and Sensitivity analysis of exponential growth of epidemic curve (C). 343 344 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 26, 2020. . 

European Centre for Disease Prevention and Control. Geographic distribution of 254

COVID-19 cases worldwide. European Centre for Disease Prevention and Control

The global spread of 2019-nCoV: a molecular evolutionary analysis. Pathog Glob 257

A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics 260 of SARS-CoV-2 lineages

Bayesian phylodynamic inference on the temporal 262 evolution and global transmission of SARS-CoV-2

Phylodynamic analyses based on 93 genomes

Evolutionary history and phylogeography of human viruses

Phylodynamic 274 applications in 21(st) century global infectious disease research

The R0 package: a toolbox to estimate 277 reproduction numbers for epidemic outbreaks

How generation intervals shape the relationship between 279 growth rates and reproductive numbers

A likelihood-based method for real-time estimation of the 281 serial interval and reproductive number of an epidemic

Temporal dynamics in viral 283 shedding and transmissibility of COVID-19

Different epidemic curves for severe acute respiratory 285 syndrome reveal similar impacts of control measures

disease and diplomacy: GISAID's innovative 287 contribution to global health

MAFFT multiple sequence alignment software version 7: 289 improvements in performance and usability

Application of phylogenetic networks in evolutionary studies

jModelTest 2: more models, new 293 heuristics and parallel computing

New 295 hCoV-19/Brazil